Xue Yang

Ms. Xue Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in IEEE Signal Processing Letters
Verified
Journal Article
Closed access
HKHaopeng Kuang
Haopeng Kuang
XYXue Yang
Xue Yang
HLHongjun Li
Hongjun Li
JWJingwei Wei
Jingwei Wei
LZLihua Zhang
Lihua Zhang
The segmentation of liver tumors using multi-phase computed tomography (CT) images has garnered considerable attention in medical signal processing. However, existing multi-phase liver tumor segmentation methods primarily concentrate on feature integration across various phases, neglecting a comprehensive exploration of synergistic relationships among these phases and constraints on features across different scales. This limitation has led to performance bottlenecks in existing approaches. This article proposes a robust multi-phase liver tumor segmentation framework designed to address the aforementioned challenges. Specifically, we introduce a novel multi-phase and channel-stacked dual attention module, seamlessly integrated within a multi-scale architecture. This module adaptively captures essential semantic information among different phases, enhancing the segmentation network's feature extraction capabilities. A scale-weighted loss function for multi-scale supervision is also designed to mitigate false positives in the segmentation results. To facilitate a systematic evaluation of our model's performance on multi-phase data, we curate a new dataset comprising samples from four distinct phases. Our proposed framework is rigorously assessed through comprehensive quantitative and qualitative experiments, highlighting its compelling performance.

21 October 2021 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
JLJing Liu
Jing Liu
XYXue Yang
Xue Yang
YZYunxian Zhu
Yunxian Zhu
YZYi Zhu
Yi Zhu
JLJingzhe Liu
Jingzhe Liu
HLHongjun Li
Hongjun Li
Background: The computed tomography (CT) diagnostic value of COVID-19 is controversial. We summarized the value of chest CT in the diagnosis of COVID-19 through a meta-analysis based on the reference standard. Methods: All Chinese and English studies related to the diagnostic value of CT for COVID-19 across multiple publication platforms, was searched for and collected. Studies quality evaluation and plotting the risk of bias were estimated. A heterogeneity test and meta-analysis, including plotting sensitivity (Sen), specificity (Spe) forest plots, pooled positive likelihood ratio (+LR), negative likelihood ratio (-LR), dignostic odds ratio (DOR) values and 95% confidence interval (CI), were estimated. If there was a threshold effect, summary receiver operating characteristic curves (SROC) was further plotted. Pooled area under the receiver operating characteristic curve (AUROC) and 95% CI were also calculated. Results: Twenty diagnostic studies that represented a total of 9004 patients were included from 20 pieces of literatures after assessing all the aggregated studies. The reason for heterogeneity was caused by the threshold effect, so the AUROC = 0.91 (95% CI: 0.89–0.94) for chest CT of COVID-19. Pooled sensitivity, specificity, +LR, -LR from 20 studies were 0.91 (95% CI: 0.88–0.94), 0.71 (95% CI: 0.59–0.80), 3.1(95% CI: 2.2–4.4), 0.12 (95% CI: 0.09–0.17), separately. The I2 was 85.6% (P = 0.001) by Q-test. Conclusions: The results of this study showed that CT diagnosis of COVID-19 was close to the reference standard. The diagnostic value of chest CT may be further enhanced if there is a unified COVID-19 diagnostic standard. However, please pay attention to rational use of CT. Graphic